Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Perampanel outcomes at different stages of treatment in people with focal and generalized epilepsy treated in clinical practice: Evidence from the PERMIT study.
Liguori C, Santamarina E, Strzelczyk A, Rodríguez-Uranga JJ, Shankar R, Rodríguez-Osorio X, Auvin S, Bonanni P, Trinka E, McMurray R, Sáinz-Fuertes R, Villanueva V. Liguori C, et al. Among authors: rodriguez uranga jj. Front Neurol. 2023 Mar 30;14:1120150. doi: 10.3389/fneur.2023.1120150. eCollection 2023. Front Neurol. 2023. PMID: 37064177 Free PMC article.
Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA).
Falip M, López González FJ, Martín-Herranz I, Merino-Bohórquez V, Montoya J, Rey Gómez-Serranillos I, Rodriguez Uranga JJ, Ruiz E, Sancho-López A, Trillo Mata JL, Antoni Vallès J, Álvarez-Barón E, Sabaniego J, Subías-Labazuy S, Gil A. Falip M, et al. Among authors: rodriguez uranga jj. Epilepsy Behav. 2023 Aug;145:109350. doi: 10.1016/j.yebeh.2023.109350. Epub 2023 Jul 20. Epilepsy Behav. 2023. PMID: 37480633 Free article.
Cenobamate and Clobazam Combination as Personalized Medicine in Autoimmune-Associated Epilepsy With Anti-Gad65 Antibodies.
Serrano-Castro PJ, Rodríguez-Uranga JJ, Cabezudo-García P, García-Martín G, Romero-Godoy J, Estivill-Torrús G, Ciano-Petersen NL, Oliver B, Ortega-Pinazo J, López-Moreno Y, Aguilar-Castillo MJ, Gutierrez-Cardo AL, Ramírez-García T, Sanchez-Godoy L, Carreño M. Serrano-Castro PJ, et al. Among authors: rodriguez uranga jj. Neurol Neuroimmunol Neuroinflamm. 2023 Aug 22;10(6):e200151. doi: 10.1212/NXI.0000000000200151. Print 2023 Nov. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37607753 Free PMC article.
Real-world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program.
Villanueva V, Santos-Carrasco D, Cabezudo-García P, Gómez-Ibáñez A, Garcés M, Serrano-Castro P, Castro-Vilanova MD, Sayas D, Lopez-Gonzalez FJ, Rodríguez-Osorio X, Torres-Gaona G, Saiz-Diaz RA, Hampel KG, Martinez-Ferri M, Aguilar-Amat MJ, Mercedes-Alvarez B, García-Morales V, Del Villar-Igea A, Massot-Tarrús A, Rodríguez-Uranga JJ. Villanueva V, et al. Among authors: rodriguez uranga jj. Epilepsia Open. 2023 Sep;8(3):918-929. doi: 10.1002/epi4.12757. Epub 2023 May 21. Epilepsia Open. 2023. PMID: 37149853 Free PMC article.
Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial.
Vossler DG, Knake S, O'Brien TJ, Watanabe M, Brock M, Steiniger-Brach B, Williams P, Roebling R; SP0982 co-investigators. Vossler DG, et al. J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1067-1075. doi: 10.1136/jnnp-2020-323524. Epub 2020 Aug 18. J Neurol Neurosurg Psychiatry. 2020. PMID: 32817358 Free PMC article. Clinical Trial.
Corrigendum to "Effectiveness and safety of perampanel as early add-on treatment in patients with epilepsy and focal seizures in the routine clinical practice: Spain prospective study (PERADON)" [Epilepsy Behav 102 (2020) 106655].
Abril Jaramillo J, Estévez María JC, Girón Úbeda JM, Vega López Ó, Calzado Rivas ME, Pérez Díaz H, García Martín G, Herrero EV, Chamorro Muñoz MI, Vázquez Gutiérrez F, de la Fuente Cañete C, Redondo Verge L, Peláez Viña N, Santágueda P, Rodríguez Uranga JJ. Abril Jaramillo J, et al. Among authors: rodriguez uranga jj. Epilepsy Behav. 2020 Mar;104(Pt A):106917. doi: 10.1016/j.yebeh.2020.106917. Epub 2020 Jan 28. Epilepsy Behav. 2020. PMID: 32005527 No abstract available.
Effectiveness and safety of perampanel as early add-on treatment in patients with epilepsy and focal seizures in the routine clinical practice: Spain prospective study (PERADON).
Abril Jaramillo J, Estévez María JC, Girón Úbeda JM, Vega López Ó, Calzado Rivas ME, Pérez Díaz H, García Martín G, Vila Herrero E, Chamorro-Muñoz M, Vázquez F, De la Fuente C, Redondo L, Peláez N, Santágueda P, Rodríguez Uranga JJ. Abril Jaramillo J, et al. Among authors: rodriguez uranga jj. Epilepsy Behav. 2020 Jan;102:106655. doi: 10.1016/j.yebeh.2019.106655. Epub 2019 Dec 6. Epilepsy Behav. 2020. PMID: 31812902
MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy.
Villanueva V, Bermejo P, Montoya J, Massot-Tarrús A, Galiano ML, Toledo M, Rodriguez-Uranga JJ, Bertol V, Mauri JÁ, Poza JJ, Bonet M, Castro-Vilanova MD, Ruiz-Giménez J, López-González FJ, Rodríguez-Osorio X, Tortosa-Conesa D, Ojeda J, Giner P, Garcés M, Alvarez BM, Quiroga-Subirana P, Esteve P, Baiges JJ, Hampel K. Villanueva V, et al. Among authors: rodriguez uranga jj. Epilepsy Behav. 2019 Aug;97:51-59. doi: 10.1016/j.yebeh.2019.05.003. Epub 2019 Jun 7. Epilepsy Behav. 2019. PMID: 31181429
39 results